BETTER THERAPEUTICS INC's ticker is and the CUSIP is 08773T104. A total of 16 filers reported holding BETTER THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,986 | -66.0% | 31,066 | -35.8% | 0.00% | – |
| Q1 2023 | $35,235 | -87.4% | 48,400 | -80.6% | 0.00% | – |
| Q4 2022 | $279,104 | -34.3% | 249,200 | +3.2% | 0.00% | – |
| Q3 2022 | $425,000 | +150.0% | 241,400 | +121.7% | 0.00% | – |
| Q2 2022 | $170,000 | -19.8% | 108,900 | +1.6% | 0.00% | – |
| Q1 2022 | $212,000 | -66.6% | 107,135 | -21.4% | 0.00% | – |
| Q4 2021 | $634,000 | – | 136,313 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT LLC | 1,000,000 | $1,560,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 14,627 | $23,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 73,800 | $115,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 65 | $0 | 0.00% |
| NORTHERN TRUST CORP | 16,703 | $26,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 37,944 | $59,000 | 0.00% |
| STATE STREET CORP | 45,200 | $71,000 | 0.00% |
| MORGAN STANLEY | 93,973 | $147,000 | 0.00% |
| BlackRock Inc. | 75,948 | $118,000 | 0.00% |